Stock Events

Stock Events

Clearmind Medicine 

$1.05
0
-$0.04-3.67% Today

Statistics

Day High
1.08
Day Low
1.04
52W High
-
52W Low
-
Volume
392
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CMND.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap746.47M
COMPASS Pathways is focused on psilocybin therapy for mental health conditions, competing in the psychedelic medicine sector alongside Clearmind Medicine.
AtaiBeckley
ATAI
Mkt Cap1.38B
ATAI Life Sciences is a biotech company developing treatments for mental health disorders, including psychedelic and non-psychedelic compounds, making it a competitor in the broader mental health treatment market.
GH Research
GHRS
Mkt Cap903.77M
GH Research is developing 5-MeO-DMT therapies for depression, a direct competitor in the psychedelic treatment market for mental health, similar to Clearmind's objectives.
Cybin Inc
CYBN
Mkt Cap413.12M
Cybin Inc. is working on psychedelic therapeutics for psychiatric and neurological conditions, directly competing with Clearmind Medicine in the psychedelic medicine space.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness is engaged in the development of psychedelic therapies and wellness services, competing in the same sector as Clearmind Medicine.
MiniMed Group
MMED
Mkt Cap0
MindMedicine (MindMed) Inc. is another key player in the psychedelic medicine space, focusing on developing treatments for mental illness and addiction, directly competing with Clearmind Medicine.
Revive Therapeutics
RVVTF
Mkt Cap12.2M
Revive Therapeutics is exploring the use of psychedelics in treatments, including psilocybin for substance abuse, positioning it as a competitor in the psychedelic therapy market.

About

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
Show more...
CEO
Dr. Adi Zuloff-Shani Ph.D.
Employees
4
Country
CA
ISIN
CA1850535016

Listings

F
DE
CWY.F
XNAS
US
CMND
BOATS
BOATS
CMND.BOATS

0 Comments

Share your thoughts

FAQ

What is Clearmind Medicine stock price today?▼
The current price of CMND.BOATS is $1.05 USD — it has decreased by -3.67% in the past 24 hours. Watch Clearmind Medicine stock price performance more closely on the chart.
What is Clearmind Medicine stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Clearmind Medicine stocks are traded under the ticker CMND.BOATS.
How many employees does Clearmind Medicine have?▼
As of April 06, 2026, the company has 4 employees.
In which sector is Clearmind Medicine located?▼
Clearmind Medicine operates in the Health Care sector.
When did Clearmind Medicine complete a stock split?▼
Clearmind Medicine has not had any recent stock splits.
Where is Clearmind Medicine headquartered?▼
Clearmind Medicine is headquartered in Vancouver, CA.